natgillin/translations-raw huggingface dataset:
One film-coated tablet of Levetiracetam ratiopharm 1000 mg contains 1000 mg levetiracetam. 
Jedna filmom obložena tableta Levetiracetam ratiopharm 1000 mg sadrži 1000 mg levetiracetama.
Concomitant administration of levetiracetam and methotrexate has been reported to decrease methotrexate clearance, resulting in increased/prolonged blood methotrexate concentration to potentially toxic levels. 
što uzrokuje povišenu/zadržanu koncentraciju metotreksata u krvi do potencijalno toksičnih razina.
Levetiracetam ratiopharm 100 mg/ml oral solution Levetiracetam 
Levetiracetam ratiopharm 100 mg/ml oralna otopina levetiracetam
Linear and dose proportional increases were observed for peak plasma concentrations and area under the curve. 
Za vršne koncentracije u plazmi i površinu ispod krivulje primijećena su linearna povećanja i proporcionalna s dozom.
7 to 14 mg/kg (0.07 to 0.14 ml/kg)once daily (2) (4) 
7 do 14 mg/kg (0,07 do 0,14 ml/kg) jedanput na dan (2) (4)
A dose of 20 mg/kg/day titrating to 40 mg/kg/day for infants one month to less than six months and a dose of 25 mg/kg/day titrating to 50 mg/kg/day for infants and children 6 months to less than 4 years old, was use in this study. 
25 mg/kg/dan titrirana je do 50 mg/kg/dan u dojenčadi i djece u dobi od 6 mjeseci do manje od 4
Levetiracetam ratiopharm 750 mg film-coated tablets EU/1/11/702/018 
Levetiracetam ratiopharm 750 mg filmom obložene tablete EU/1/11/702/018
Levetiracetam ratiopharm 250 mg film-coated tablets EU/1/11/702/004 
Levetiracetam ratiopharm 250 mg filmom obložene tablete EU/1/11/702/004
10 film-coated tablets 20 film-coated tablets 30 film-coated tablets 50 film-coated tablets 60 film-coated tablets 100 film-coated tablets 
10 filmom obloženih tableta 20 filmom obloženih tableta 30 filmom obloženih tableta 50 filmom obloženih tableta 60 filmom obloženih tableta 100 filmom obloženih tableta
20 film-coated tablets 30 film-coated tablets 50 film-coated tablets 60 film-coated tablets 80 film-coated tablets 100 film-coated tablets 
20 filmom obloženih tableta 30 filmom obloženih tableta 50 filmom obloženih tableta 60 filmom obloženih tableta 80 filmom obloženih tableta 100 filmom obloženih tableta
How to take Levetiracetam ratiopharm 
Kako uzimati Levetiracetam ratiopharm
In order to ensure the accuracy of the dosing, this presentation should be prescribed for infants aged 1 month to less than 6 months. 
Kako bi se osiguralo točno doziranje to pakiranje treba propisivati dojenčadi u dobi od 1
One film-coated tablet of Levetiracetam ratiopharm 500 mg contains 500 mg levetiracetam. 
Jedna filmom obložena tableta Levetiracetam ratiopharm 500 mg sadrži 500 mg levetiracetama.
Suicide attempt, suicidal ideation, psychotic disorder, abnormal behaviour, hallucination, anger, confusional state , panic attack, affect lability/mood swings, agitation 
psihotični poremećaj, poremećaj ponašanja, halucinacije, srditost, konfuzno stanje, napadaj panike labilnost afekta/promjene raspoloženja, agitacija
Levetiracetam ratiopharm 1000 mg film-coated tablets EU/1/11/702/025 
Levetiracetam ratiopharm 1000 mg filmom obložene tablete EU/1/11/702/025
One film-coated tablet of Levetiracetam ratiopharm 250 mg contains 250 mg levetiracetam. 
Jedna filmom obložena tableta Levetiracetam ratiopharm 250 mg sadrži 250 mg levetiracetama.
Johnson syndrome), and a more severe form causing skin peeling in more than 30% of the body surface (toxic epidermal necrolysis). 
(Stevens-Johnsonov sindrom), i mnogo teži oblik koji uzrokuje ljuštenje kože na više od 30%
One film-coated tablet of Levetiracetam ratiopharm 750 mg contains 750 mg levetiracetam. 
Jedna filmom obložena tableta Levetiracetam ratiopharm 750 mg sadrži 750 mg levetiracetama.
20 film-coated tablets 30 film-coated tablets 50 film-coated tablets 60 film-coated tablets 100 film-coated tablets 
20 filmom obloženih tableta 30 filmom obloženih tableta 50 filmom obloženih tableta 60 filmom obloženih tableta 100 filmom obloženih tableta
The 150 ml glass bottle of Levetiracetam ratiopharm oral solution (for infants aged 6 months and above and children aged 2 to 4 years) is packed in a cardboard box containing a 3 ml oral syringe (graduated every 0.1 ml) and an adaptor for the syringe. 
Staklena boca od 150 ml Levetiracetam ratiopharm oralne otopine (za dojenčad i malu djecu u dobi od 6 mjeseci do manje od 4 godine) pakirana je u kartonsku kutiju koja još sadrži štrcaljku za usta od 3 ml (s oznakom na svakih 0,1 ml) i nastavak za štrcaljku.
Levetiracetam ratiopharm 500 mg film-coated tablets The 500 mg film-coated tablets are yellow, oval and scored on one side. 
Levetiracetam ratiopharm 500 mg filmom obložene tablete 500 mg filmom obložene tablete su žute, duguljaste tablete s razdjelnom crtom na jednoj strani.
Each ml oral solution contains 100 mg levetiracetam. 
Jedan ml oralne otopine sadrži 100 mg levetiracetama.
35 infants aged less than 1 year with partial onset seizures have been exposed in placebo-control clinical studies of which only 13 were aged < 6 months. 
1 godine s parcijalnim napadajima, a samo je njih 13 bilo u dobi <6 mjeseci.
How to store Levetiracetam ratiopharm 
Kako čuvati Levetiracetam ratiopharm
Each film-coated tablet contains 1000 mg levetiracetam. 
Jedna filmom obložena tableta sadrži 1000 mg levetiracetama.
Levetiracetam ratiopharm 750 mg film-coated tablets The 750 mg film-coated tablets are light red, oblong and scored on both sides. 
Levetiracetam ratiopharm 750 mg filmom obložene tablete 750 mg filmom obložene tablete su svijetlocrvene, duguljaste tablete s razdjelnom crtom na obje strane.
General dose: Levetiracetam ratiopharm is taken twice daily, in two equally divided doses, each individual dose being measured between 0.1 ml (10 mg) and 0.3 ml (30 mg), per kg bodyweight of the child. (see table below for dose examples). 
Uobičajena doza: Levetiracetam ratiopharm se uzima dva puta na dan, u dvije jednake doze, pri čemu svaka pojedinačna doza iznosi između 0,1 ml (10 mg) i 0,3 ml (30 mg) po kilogramu tjelesne težine djeteta.
100 mg (1 ml) twice daily 
100 mg (1 ml) dva puta na dan
Dose in children 6 months and older 
Doza u djece od navršenih 6 mjeseci nadalje
28 mg (0.3 ml) twice daily 84 mg (0.85 ml) twice daily 
84 mg (0,85 ml) dva puta na dan
Add-on therapy for infants aged from 6 to 23 months, children (2 to 11 years) and adolescents (12 to 17 years) weighing less than 50 kg 
Dodatna terapija za dojenčad u dobi od 6. do 23. mjeseca, djecu (2 do 11 godina) i adolescente (12 do 17 godina) s manje od 50 kg tjelesne težine
(1) Children 25 kg or less should preferably start the treatment with Levetiracetam ratiopharm 
1500 mg dva puta na dan (1) U djece od 25 kg ili manje liječenje je najbolje započeti Levetiracetam ratiopharm 100 mg/ml oralnom otopinom.
• skin rash, which may form blisters and looks like small targets (central dark spots surrounded by a paler area, with a dark ring around the edge) (erythema multiforme), a widespread rash with blisters and peeling skin, particularly around the mouth, nose, eyes and genitals (StevensJohnson syndrome), and a more severe form causing skin peeling in more than 30% of the body surface (toxic epidermal necrolysis). 
• kožni osip koji može tvoriti mjehure i izgledati poput malih meta (središnje tamne mrlje okružene svijetlim područjem, s tamnim prstenom oko ruba) (multiformni eritem) • rasprostranjeni osip s mjehurićima i kožom koja se ljušti, posebice oko usta, nosa, očiju i genitalija (Stevens-Johnsonov sindrom)
300 mg (3 ml) twice daily 
300 mg (3 ml) dva puta na dan
PARTICULARS TO APPEAR ON THE OUTER PACKAGING Carton for bottles - 300 ml (10 ml syringe) 
PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKIRANJU Kutija za boce - 300 ml (štrcaljka od 10 ml)
Levetiracetam ratiopharm 750 mg film-coated tablets Each film-coated tablet contains 750 mg levetiracetam. 
Levetiracetam ratiopharm 750 mg filmom obložene tablete Jedna filmom obložena tableta sadrži 750 mg levetiracetama.
600 mg (6 ml) twice daily 
600 mg (6 ml) dva puta na dan
Levetiracetam ratiopharm 250 mg film-coated tablets Each film-coated tablet contains 250 mg levetiracetam. 
Levetiracetam ratiopharm 250 mg filmom obložene tablete Jedna filmom obložena tableta sadrži 250 mg levetiracetama.
CLcr (ml/min/1.73 m2) = ---------------------------- x 1.73 
CLcr (ml/min) CLcr (ml/min/1,73 m2) = --------------------------------- x 1,73 PT bolesnika (m2)
Levetiracetam ratiopharm 500 mg film-coated tablets Each film-coated tablet contains 500 mg levetiracetam. 
Levetiracetam ratiopharm 500 mg filmom obložene tablete Jedna filmom obložena tableta sadrži 500 mg levetiracetama.
Levetiracetam ratiopharm 1000 mg film-coated tablets Each film-coated tablet contains 1000 mg levetiracetam. 
Levetiracetam ratiopharm 1000 mg filmom obložene tablete Jedna filmom obložena tableta sadrži 1000 mg levetiracetama.
Pancytopenia , neutropenia, agranulocytosis 
Pancitopenija neutropenija, agranulocitoza
300 ml brown glass bottle (type III) with a white child resistant closure (polypropylene) in a cardboard box also containing a 10 ml graduated oral syringe (polypropylene, polyethylene) and an adaptor for the syringe (polyethylene). 
Smeđa staklena boca od 300 ml (staklo tip III) s bijelim sigurnosnim zatvaračem za djecu (polipropilen) u kartonskoj kutiji koja također sadrži graduiranu štrcaljku za usta od 10 ml
(1) Levetiracetam ratiopharm 100 mg/ml oral solution should be used for doses under 125 mg, for doses not multiple of 125 mg when dosing recommendation is not achievable by taking multiple tablets and for patients unable to swallow tablets. 
0,20 ml/kg) jednaput na dan (1) Za doze ispod 125 mg, za doze koje nisu višekratnici doze od 125 mg kada se preporučeno doziranje ne može postići uzimanjem većeg broja tableta i kod bolesnika koji ne mogu gutati tablete treba koristiti Levetiracetam ratiopharm 100 mg/ml oralnu otopinu.
Levetiracetam ratiopharm 1000 mg film-coated tablets Hypromellose (E464), Microcrystalline cellulose (E460), Macrogol 40 stearate type I, Titanium dioxide (E171) 
Levetiracetam ratiopharm 1000 mg filmom obložene tablete Hipromeloza (E464), mikrokristalična celuloza (E460), makrogol 40 stearat vrste I, titanijev dioksid (E171)
- A 150 ml bottle with a 3 ml oral syringe (delivering up to 300 mg levetiracetam) graduated every 0.1 ml (corresponding to 10 mg) 
- Bočica od 150 ml s 3 ml štrcaljkom za usta (kojom se dostavlja do 300 mg levetiracetama)
The most frequently reported side effects are nasopharyngitis, somnolence (sleepiness), headache, fatigue and dizziness. 
Najčešće prijavljene nuspojave su nazofaringitis, izrazita pospanost, glavobolja, umor i omaglica.
Hypromellose (E464), Microcrystalline cellulose (E460), Macrogol 40 stearate type I, Titanium dioxide (E171) 
Hipromeloza (E464), celuloza, mikrokristalična (E460), makrogol 40 stearat vrste I, titanijev dioksid (E171).
150 ml brown glass bottle (type III) with a white child resistant closure (polypropylene) in a cardboard box also containing a 1 ml graduated oral syringe (polypropylene, polyethylene) and an adaptor for the syringe (polyethylene). 
Smeđa staklena boca od 150 ml (staklo tip III) s bijelim sigurnosnim zatvaračem za djecu (polipropilen) u kartonskoj kutiji koja također sadrži graduiranu štrcaljku za usta od 1 ml
Levetiracetam ratiopharm 750 mg film-coated tablets Levetiracetam 
Levetiracetam ratiopharm 750 mg tablete levetiracetam
Film-coated tablets are yellow, oval and scored on one side and are supplied in packs of 10, 20, 30, 50, 60 or 100 film-coated tablets or multipacks of 120 (2 packs of 60) or 200 (2 packs of 100) film-coated tablets. 
Filmom obložene tablete su žute, duguljaste tablete s razdjelnom crtom na jednoj strani i dostupne su u pakiranjima od 10, 20, 30, 50, 60 ili 100 filmom obloženih tableta ili višestrukim pakiranjima koja sadrže 120 (2 pakiranja od 60) ili 200 (2 pakiranja od 100) filmom obloženih tableta.
150 ml brown glass bottle (type III) with a white child resistant closure (polypropylene) in a cardboard box also containing a 3 ml graduated oral syringe (polypropylene, polyethylene) and an adaptor for the syringe (polyethylene). 
Smeđa staklena boca od 150 ml (staklo tip III) s bijelim sigurnosnim zatvaračem za djecu (polipropilen) u kartonskoj kutiji koja također sadrži graduiranu štrcaljku za usta od 3 ml
Levetiracetam ratiopharm 250 mg film-coated tablets Levetiracetam 
Levetiracetam ratiopharm 250 mg tablete levetiracetam
PARTICULARS TO APPEAR ON THE OUTER PACKAGING Carton for bottles - 150 ml (1 ml syringe) 
PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKIRANJU Kutija za boce - 150 ml (štrcaljka od 1 ml)
200 mg (2 ml) twice daily 
200 mg (2 ml) dva puta na dan
CLcr (ml/min/1.73 m2) = ---------------------------- x 1.73 BSA subject (m2) 
CLcr (ml/min) CLcr (ml/min/1,73 m2) = ------------------------------ x 1,73 PT bolesnika (m2)
Levetiracetam ratiopharm 750 mg film-coated tablets Hypromellose (E464), Microcrystalline cellulose (E460), Macrogol 40 stearate type I, Anatase titanium dioxide (E171), Yellow Iron Oxide (E172), Red Iron Oxide (E172) 
Levetiracetam ratiopharm 750 mg filmom obložene tablete Hipromeloza (E464), mikrokristalična celuloza (E460), makrogol 40 stearat vrste I, titanijev dioksid anatas (E171), željezov oksid žuti (E172), željezov oksid crveni (E172)
Levetiracetam ratiopharm 500 mg film-coated tablets Levetiracetam 
Levetiracetam ratiopharm 500 mg tablete levetiracetam
Levetiracetam ratiopharm 1000 mg film-coated tablets Levetiracetam 
Levetiracetam ratiopharm 1000 mg filmom obložene tablete levetiracetam
- A 150 ml bottle with a 1 ml oral syringe (delivering up to 100 mg levetiracetam) graduated every 0.05 ml (corresponding to 5 mg) 
- Bočica od 150 ml s 1 ml štrcaljkom za usta (kojom se dostavlja do 100 mg levetiracetama)
35 mg (0.35 ml) twice daily 105 mg (1.05 ml) twice daily 
105 mg (1,05 ml) dva puta na dan
PARTICULARS TO APPEAR ON THE OUTER PACKAGING Carton for bottles - 150 ml (3 ml syringe) 
PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKIRANJU Kutija za boce - 150 ml (štrcaljka od 3 ml)
Levetiracetam ratiopharm 1000 mg film-coated tablets 
Levetiracetam ratiopharm 1000 mg filmom obložene tablete
Tel: +421 2 57 26 79 11 
Teva Pharmaceuticals Slovakia s.r.o. Tel: +421 2 57 26 79 11
49 mg (0.5 ml)twice daily 147 mg (1.5 ml) twice daily 
147 mg (1,5 ml) dva puta na dan
Levetiracetam ratiopharm 500 mg film-coated tablets Hypromellose (E464), Microcrystalline cellulose (E460), Macrogol 40 stearate type I, Anatase titanium dioxide (E171), Yellow Iron Oxide (E 172) 
Levetiracetam ratiopharm 500 mg filmom obložene tablete hipromeloza (E464), mikrokristalična celuloza (E460), makrogol 40 stearat vrste I, titanijev dioksid anatas (E171), željezov oksid žuti (E172)
5 ml twice daily 
5 ml dva puta na dan
Levetiracetam ratiopharm 750 mg film-coated tablets 
Levetiracetam ratiopharm 750 mg filmom obložene tablete
Levetiracetam ratiopharm 500 mg film-coated tablets 
Levetiracetam ratiopharm 500 mg filmom obložene tablete
Hypromellose (E464), Microcrystalline cellulose (E460), Macrogol 40 stearate type I, Anatase titanium dioxide (E171), Yellow Iron Oxide (E172), Red Iron Oxide (E172) 
Hipromeloza (E464), celuloza, mikrokristalična (E460), makrogol 40 stearat vrste I, titanijev dioksid anatas (E171), željezov oksid, žuti (E172), željezov oksid, crveni (E 172).
Film-coated tablets are white, oblong and scored on both sides and are supplied in packs of 10, 20, 30, 50, 60 or 100 film-coated tablets or multipacks of 200 (2 packs of 100) film-coated tablets. 
Filmom obložene tablete su su bijele, duguljaste tablete s razdjelnom crtom na obje strane i dostupne su u pakiranjima od 10, 20, 30, 50, 60 ili 100 filmom obloženih tableta ili višestrukim pakiranjima koja sadrže 200 (2 pakiranja od 100) filmom obloženih tableta.
Hypromellose (E464), Microcrystalline cellulose (E460), Macrogol 40 stearate type I, Anatase titanium dioxide (E171), Yellow Iron Oxide (E 172) 
Hipromeloza (E464), celuloza, mikrokristalična (E460), makrogol 40 stearat vrste I, titanijev dioksid anatas (E171), željezov oksid, žuti (E172).
Quincke's oedema [swelling of the face, lips, tongue and throat]); 
angioedem [oticanje lica, usana, jezika i grla]); • snižena koncentracija natrija u krvi;
Package Leaflet: Information for the patient Levetiracetam ratiopharm 100 mg/ml oral solution. 
Najprikladniji farmaceutski oblik za primjenu u toj populaciji je Levetiracetam ratiopharm 100 mg/ml oralna otopina.
Levetiracetam ratiopharm 250 mg film-coated tablets 
Levetiracetam ratiopharm 250 mg filmom obložene tablete
Film-coated tablets are blue, oblong and scored on one side and are supplied in packs of 20, 30, 50, 60 or 100 film-coated tablets or multipacks of 200 (2 packs of 100) film-coated tablets. 
Filmom obložene tablete su plave, duguljaste tablete s razdjelnom crtom na jednoj strani i dostupne su u pakiranjima od 20, 30, 50, 60 ili 100 filmom obloženih tableta ili višestrukim pakiranjima koja sadrže 200 (2 pakiranja od 100) filmom obloženih tableta.
Levetiracetam ratiopharm may impair your ability to drive or operate any tools or machinery, as it may make you feel sleepy. 
Ako vozite ili upravljate alatima ili vozilima potreban je oprez jer se pri uzimanju Levetiracetama ratiopharm može javiti osjećaj pospanosti.
Excipients 
Kašalj
Film-coated tablets are light red coloured, oblong and scored on both sides and are supplied in packs of 20, 30, 50, 60, 80 or 100 film-coated tablets or multipacks of 200 (2 packs of 100) film-coated tablets. 
Filmom obložene tablete su su svijetlocrvene, duguljaste tablete s razdjelnom crtom na obje strane i dostupne su u pakiranjima od 20, 30, 50, 60, 80 ili 100 filmom obloženih tableta ili višestrukim pakiranjima koja sadrže 200 (2 pakiranja od 100) filmom obloženih tableta.
Levetiracetam ratiopharm 500 mg film-coated tablets Packs containing 10, 20, 30, 50, 60 or 100 film-coated tablets or multipacks containing 120 (2 packs of 60) or 200 (2 packs of 100) film-coated tablets. 
Pakiranja koja sadrže 10, 20, 30, 50, 60 ili 100 filmom obloženih tableta ili višestruka pakiranja koja sadrže 120 (2 pakiranja od 60) ili 200 (2 pakiranja od 100) filmom obloženih tableta.
PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING Bottle label - 300 ml (10 ml syringe) 
PODACI KOJE MORA NAJMANJE SADRŽAVATI UNUTARNJE PAKIRANJE Naljepnica za bocu - 300 ml (štrcaljka od 10 ml)
Starting dose: 0.07 ml/kg twice daily 
0,07 ml/kg dva puta na dan
Levetiracetam ratiopharm 250 mg film-coated tablets Packs containing 20, 30, 50, 60 or 100 film-coated tablets or multipacks containing 200 (2 packs of 100) film-coated tablets. 
Pakiranja koja sadrže 20, 30, 50, 60, 80 ili 100 filmom obloženih tableta ili višestruka pakiranja koja sadrže 200 (2 pakiranja od 100) filmom obloženih tableta.
EXP See outer carton 
EXP Pogledati kutiju.
To take as follows: [Box for the prescription dose] 
[Prostor za propisano doziranje]
Levetiracetam ratiopharm 100 mg/ml oral solution 
Levetiracetam ratiopharm 100 mg/ml oralna otopina
• in the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with Idiopathic Generalised Epilepsy. 
• u liječenju primarno generaliziranih toničko-kloničkih napadaja u odraslih i adolescenata od
Starting dose: 0.1 ml/kg twice daily 
0,1 ml/kg dva puta na dan
• a widespread rash with blisters and peeling skin, particularly around the mouth, nose, eyes and genitals (Stevens-Johnson syndrome) 
jako rasprostranjen osip s mjehurma i kožom koja se ljušti, osobito oko usta, nosa, očiju i genitalija (Stevens-Johnsonov sindrom), i mnogo teži oblik koji uzrokuje ljuštenje kože na više od 30% površine tijela (toksična epidermalna nekroliza).
PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING Bottle label - 150 ml (1 ml syringe) 
PODACI KOJE MORA NAJMANJE SADRŽAVATI UNUTARNJE PAKIRANJE Naljepnica za bocu - 150 ml (štrcaljka od 1 ml)
PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING Bottle label - 150 ml (3 ml syringe) 
PODACI KOJE MORA NAJMANJE SADRŽAVATI UNUTARNJE PAKIRANJE Naljepnica za bocu - 150 ml (štrcaljka od 3 ml)
CLcr (ml/min) = ----------------------------------------- (x 0.85 for women) 
CLcr (ml/min) = ----------------------------------------------- (x 0,85 za žene) 72 x kreatinin u serumu (mg/dl)
Starting dose: 7 mg/kg twice daily 
7 mg/kg dva puta na dan
There are no other ingredients. 
- Nema drugih sastojaka.
Talk to your doctor as soon as possible. 
Razgovarajte sa svojim liječnikom što je prije moguće.
You may have a fever and be very tired 
Možete imati vrućicu i osjećati se vrlo umorno.
less than 10 
manje od 10
Other medicines may also be given at the same time. 
Istodobno se mogu primjenjivati i drugi lijekovi.
Sometimes you may get less severe skin reactions such as: 
Ponekad se mogu pojaviti manje teške kožne reakcije, kao što su:
Take immediately. 
Odmah popijte.
It is very important that you take the antibiotic at the right dose, at the right times and for the right number of days. 
Vrlo je važno da antibiotik uzimate u točnoj dozi, u točno vrijeme i točan broj dana.
Do not drive or operate machinery unless you are feeling well. 
Nemojte upravljati vozilima ni raditi sa strojevima ako se ne osjećate dobro.
Once made up, the suspension should be used within 14 days. 
Nakon što se pripremi, suspenzija se mora upotrijebiti unutar 14 dana.
If you forget to take a dose, take it as soon as you remember. 
• Ako zaboravite uzeti dozu lijeka, uzmite je čim se sjetite.
No adjustment needed; as for adults. 
Nije potrebno prilagođavati dozu; isto kao za odrasle.
Take the medicine to show the doctor. 
Ponesite lijek kako biste ga pokazali liječniku.
• Your doctor will advise you how much Amoxil you should give to your baby or child. 
• Liječnik će Vam savjetovati koliko lijeka Amoxil trebate dati svome djetetu.
This medicinal product is authorised in the Member States of the EEA under the following names: 
Ovaj lijek je odobren u državama članicama Europskog ekonomskog prostora (EEA) pod sljedećim nazivima:
General advice regarding the use of antibiotics 
Opći savjet glede uporabe antibiotika
Do not take the next dose too soon, wait about 4 hours before taking the next dose. 
• Nemojte uzeti sljedeću dozu prebrzo, nego pričekajte približno 4 sata.
Bacteria can become resistant to antibiotics for many reasons. 
Bakterije mogu postati otporne na antibiotike zbog mnogih razloga.
The usual dose is: 
Uobičajena doza je:
• the blood may take longer to clot than it normally would. 
• za zgrušavanje krvi može trebati dulje nego inače.
• hyperactivity 
• hiperaktivnost
† Natural intermediate susceptibility in the absence of acquired mechanism of resistance. 
† Prirodna umjerena osjetljivost u odsustvu stečenih mehanizama rezistencije.
The time to peak plasma concentration (Tmax) is approximately one hour. 
Vrijeme do postizanja vršne koncentracije u plazmi (Tmax) iznosi približno jedan sat.
These can be serious and occasionally deaths have occurred 
Ove nuspojave mogu biti ozbiljne, a u nekim su slučajevima imale smrtni ishod
# In the majority of cases, parenteral therapy is preferred. 
# U većini se slučajeva prednost daje parenteralnoj terapiji.
Swallow with water without opening capsule. 
Progutati s vodom bez otvaranja kapsule.
Do not use this medicine if there are visible signs of deterioration. 
Nemojte uzeti ovaj lijek ako primijetite vidljive znakove kvarenja.
About 18% of total plasma amoxicillin is bound to protein and the apparent volume of distribution is around 0.3 to 0.4 l/kg. 
Približno 18% ukupnog amoksicilina u plazmi vezuje se za proteine, a prividni volumen distribucije iznosi približno 0,3 do 0,4 l/kg.
You will not normally be given Amoxil for more than 2 weeks without the doctor reviewing your treatment. 
Obično nećete primati Amoxil dulje od 2 tjedna, a da liječnik prije toga ponovno ne ocijeni Vaše liječenje.
• To prevent heart infection during surgery: the dose will vary according to the type of surgery. 
• Sprječavanje srčane infekcije tijekom kirurškog zahvata: doza će se razlikovati ovisno o vrsti kirurškog zahvata.
Shake until a suspension is formed. 
Tresite dok ne nastane suspenzija.
The other possible side effects are: 
Ostale moguće nuspojave su:
United Kingdom - Vials for injection 
Ujedinjeno Kraljevstvo - Vials for injection
May increase the risk of jaundice in new born babies. 
Može povećati rizik od žutice u novorođenčadi.